Harvoni 33.75 mg/150 mg and 45 mg/200 mg coated granules in sachet

*
Pharmacy Only: Prescription
  • Company:

    Gilead Sciences Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 24 November 2022

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (November 2022).pdf

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 November 2022

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (November 2022).pdf

Reasons for updating

  • Change to other sources of information section

Updated on 14 June 2022

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (May 2022).pdf

Reasons for updating

  • Removal of Black Inverted Triangle

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 14 June 2022

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (May 2022).pdf

Reasons for updating

  • Removal of Black Inverted Triangle

Updated on 09 September 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (August 2021).pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 6.3 - Shelf life

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 09 September 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (August 2021).pdf

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 28 July 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (July 2021).pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 28 July 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (July 2021).pdf

Reasons for updating

  • Change to other sources of information section

Updated on 04 June 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules SmPC (July 2020).pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 04 June 2021

File name

Harvoni 33.75 mg - 150 mg and 33.75 mg - 150 mg coated granules IE & XI PIL (May 2021).pdf

Reasons for updating

  • New PIL for new product